Cargando…

Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality

BACKGROUND: Tuberculous pericarditis is considered to be a paucibacillary process; the large pericardial fluid accumulation is attributed to an inflammatory response to tuberculoproteins. Mortality rates are high. We investigated the role of clinical and microbial factors predictive of tuberculous p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasipanodya, Jotam G., Mubanga, Mwenya, Ntsekhe, Mpiko, Pandie, Shaheen, Magazi, Beki T., Gumedze, Freedom, Myer, Landon, Gumbo, Tawanda, Mayosi, Bongani M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740299/ https://www.ncbi.nlm.nih.gov/pubmed/26870789 http://dx.doi.org/10.1016/j.ebiom.2015.09.034

Ejemplares similares

Interventions for treating tuberculous pericarditis
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study
por: Shenje, Justin, et al.
Publicado: (2019)

HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study
por: Ntsekhe, Mpiko, et al.
Publicado: (2008)

Quantification of echodensities in tuberculous pericardial effusion using fractal geometry: a proof of concept study
por: Ntsekhe, Mpiko, et al.
Publicado: (2012)

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016)

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study
por: Pandie, Shaheen, et al.
Publicado: (2014)

Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis
por: Shenje, Justin, et al.
Publicado: (2015)

Established and novel pathophysiological mechanisms of pericardial injury and constrictive pericarditis
por: Ramasamy, Vinasha, et al.
Publicado: (2018)

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2016)

The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature
por: Ntsekhe, Mpiko, et al.
Publicado: (2012)

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry
por: Mayosi, Bongani M, et al.
Publicado: (2006)

Diagnosis and Management of Tuberculous Pericarditis: What Is New?
por: Isiguzo, Godsent, et al.
Publicado: (2020)

Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion
por: Ntsekhe, Mpiko, et al.
Publicado: (2013)

Molecular characterization and antimicrobial susceptibility of  extended-spectrum b-lactamases (ESBL) producing enterobactericiaceae (ESBLPE) causing urinary tract infections (UTI): Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010–2015, South Africa
por: Magazi, Beki Temba, et al.
Publicado: (2017)

The importance of perseverance, pilot studies and the search for effective adjuvant therapies in the management of tuberculous pericarditis
por: Mutyaba, Arthur, et al.
Publicado: (2016)

Cardiovascular magnetic resonance characterisation of pericardial and myocardial involvement in patients with tuberculous pericardial constriction with and without HIV co-infection
por: Ntusi, Ntobeko A, et al.
Publicado: (2016)

A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients
por: Pasipanodya, Jotam G., et al.
Publicado: (2013)

Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse
por: Magombedze, Gesham, et al.
Publicado: (2021)

T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis()
por: Steigler, Pia, et al.
Publicado: (2022)

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
por: Deshpande, Devyani, et al.
Publicado: (2022)

Determining the Delamanid Pharmacokinetics/Pharmacodynamics Susceptibility Breakpoint Using Monte Carlo Experiments
por: Liu, Yongge, et al.
Publicado: (2023)

Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy
por: Ntusi, Ntobeko B. A., et al.
Publicado: (2015)

Therapy duration and long-term outcomes in extra-pulmonary tuberculosis
por: Pusch, Tobias, et al.
Publicado: (2014)

Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans
por: Ntusi, Ntobeko AB, et al.
Publicado: (2016)

Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis
por: Sibandze, Doctor B., et al.
Publicado: (2020)

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo
por: Deshpande, Devyani, et al.
Publicado: (2016)

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
por: Deshpande, Devyani, et al.
Publicado: (2016)

1697. Dose-response Studies of the Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, Epetraborole, in the Intracellular Hollow Fiber System Model of Mycobacterium avium complex Lung Disease
por: Chapagain, Moti, et al.
Publicado: (2022)

Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients
por: Modongo, Chawangwa, et al.
Publicado: (2015)

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2016)

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses
por: Chapagain, Moti, et al.
Publicado: (2022)

Tuberculous Pericarditis
por: Semple, Thomas
Publicado: (1948)

Tuberculous Pericarditis
por: Singh, Balbir
Publicado: (1949)

Tuberculous pericarditis
por: Jurado, Leonardo F., et al.
Publicado: (2020)

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
por: Deshpande, Devyani, et al.
Publicado: (2016)

Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence
por: Pasipanodya, Jotam G., et al.
Publicado: (2017)

Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study
por: Shaboodien, Gasnat, et al.
Publicado: (2013)

Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development
por: Gumbo, Tawanda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ttqf2j3t3esg8tip7iji5pdaf